GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Cash Flow from Financing

Molekule Group (Molekule Group) Cash Flow from Financing : $8.95 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2023, Molekule Group paid $0.00 Mil more to buy back shares than it received from issuing new shares. It spent $0.43 Mil paying down its debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $9.97 Mil on other financial activities. In all, Molekule Group earned $9.55 Mil on financial activities for the three months ended in Jun. 2023.


Molekule Group Cash Flow from Financing Historical Data

The historical data trend for Molekule Group's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Cash Flow from Financing Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Cash Flow from Financing
- 5.86 26.84 13.58

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.00 -0.42 - -0.17 9.55

Molekule Group Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Molekule Group's Cash from Financing for the fiscal year that ended in Dec. 2022 is calculated as:

Molekule Group's Cash from Financing for the quarter that ended in Jun. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molekule Group  (OTCPK:MKULQ) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Molekule Group's issuance of stock for the three months ended in Jun. 2023 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Molekule Group's repurchase of stock for the three months ended in Jun. 2023 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Molekule Group's net issuance of debt for the three months ended in Jun. 2023 was $-0.43 Mil. Molekule Group spent $0.43 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Molekule Group's net issuance of preferred for the three months ended in Jun. 2023 was $0.00 Mil. Molekule Group paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Molekule Group's cash flow for dividends for the three months ended in Jun. 2023 was $0.00 Mil. Molekule Group received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Molekule Group's other financing for the three months ended in Jun. 2023 was $9.97 Mil. Molekule Group received $9.97 Mil on other financial activities.


Molekule Group Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Molekule Group's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Molekule Group (Molekule Group) Business Description

Traded in Other Exchanges
N/A
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.
Executives
Ritankar Pal officer: Chief Operating Officer 10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris officer: Chief Commercial Officer 3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld director C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre 10 percent owner
Seth Levine 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p. 10 percent owner C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell 10 percent owner C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona officer: Chief Executive Officer 10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet director 10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410

Molekule Group (Molekule Group) Headlines